Asset Details
Do you wish to reserve the book?
Myocardial depression in sepsis: From pathogenesis to clinical manifestations and treatment
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Myocardial depression in sepsis: From pathogenesis to clinical manifestations and treatment
Do you wish to request the book?
Myocardial depression in sepsis: From pathogenesis to clinical manifestations and treatment
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Myocardial depression in sepsis: From pathogenesis to clinical manifestations and treatment
2014
Overview
The cardiovascular system plays a key role in sepsis, and septic myocardial depression is a common finding associated with increased morbidity and mortality. Myocardial depression during sepsis is not clearly defined, but it can perhaps be best described as a global (systolic and diastolic) dysfunction of both the left and right sides of the heart. The pathogenesis of septic myocardial depression involves a complex mix of systemic (hemodynamic) factors and genetic, molecular, metabolic, and structural alterations. Pulmonary artery catheterization and modern echo-Doppler techniques are important diagnostic tools in this setting. There are no specific therapies for septic myocardial depression, and the cornerstone of management is control of the underlying infectious process (adequate antibiotic therapy, removal of the source) and hemodynamic stabilization (fluids, vasopressor and inotropic agents). In this review, we will summarize the pathogenesis, diagnosis, and treatment of myocardial depression in sepsis. Additional studies are needed in order to improve diagnosis and identify therapeutic targets in septic myocardial dysfunction.
Publisher
Elsevier Inc,Elsevier Limited
Subject
/ Humans
/ Hypoxia
/ Mitochondrial Diseases - complications
/ Rodents
/ Sepsis
/ Shock, Septic - complications
/ Shock, Septic - drug therapy
/ Studies
/ Vasoconstrictor Agents - therapeutic use
/ Ventricular Dysfunction, Left - diagnosis
/ Ventricular Dysfunction, Left - etiology
/ Ventricular Dysfunction, Left - metabolism
/ Ventricular Dysfunction, Left - therapy
/ Ventricular Dysfunction, Right - diagnosis
/ Ventricular Dysfunction, Right - etiology
